SIGN IN   Advanced Search

Browse Illustration
The Athlete's Heart vs. the Failing Heart: Can Signaling Explain the Two Distinct Outcomes?- Figure 4

This figure shows the overview of key signaling pathways involved in mediating LV hypertrophy of the athlete's heart and the diseased myocardium Ang II, angiotensin II; ET-1, endothelin-1; GPCR, G protein-coupled receptor; HCM, hypertrophic cardiomyopathy; IGF1, insulin-like growth factor 1; IGF1R, IGF1 receptor; NFAT, nuclear factor of activated T cells; PI3K(p110?), phosphoinositide 3-kinase p110?.

Rate this Resource:
1 = not useful, 5 = very useful

Please be the first to rate this resource.

View Free


Resource Type: Digital Presentation (Powerpoint), Illustration, Image, Journal Article/Issue
Audience Level: Undergraduate lower division (Grades 13-14), Undergraduate upper division (Grades 15-16), Graduate, Professional (degree program), General Public, Informal Education, Continuing Education

Author and Copyright

Authors and Editors: Kate L. Weeks of Baker IDI Heart and Diabetes Institute, Julie R. McMullen of University of Melbourne Department of Biochemistry and Molecular Biology and Cardiac Hypertrophy Laboratory
Format: text/html
Copyright and other restrictions: No
Cost: No


» Sign In or register to post comments.

American Physiological Society



Triple A S National Science Foundation Naitonal Science Digital Library Pathway
Funded by the individual BEN Collaborators and grants from the
National Science Foundation [DUE 0085840 / DUE 0226185 / DUE 0532797 / DUE 0734995]

This website is a National Science Digital Library (NSDL) Pathway.
Copyright © 2019. American Association for the Advancement of Science. All Rights Reserved.